Quantcast
Last updated on April 18, 2014 at 7:29 EDT

Latest Juvenile Diabetes Research Foundation Stories

2008-08-26 15:00:17

Scientists at the Stanford University School of Medicine are shedding light on how type-1 diabetes begins. Doctors have known the disease is caused by an autoimmune attack on the pancreas, but the exact trigger of the attack has been unclear. Now, a new study in mice implicates the immune signal interferon-alpha as an early culprit in a chain of events that upend sugar metabolism and make patients dependent on lifelong insulin injections. "We never considered that interferon-alpha...

2008-08-02 00:00:06

By Stories by MADONNA YANCEY, Courier & Press correspondent Childhood should be a time filled with fun and promise. Not a time of worry and constant medical concerns. For Dana Lobel the wonder of childhood dimmed when her 10-year- old son, Ben, was diagnosed with type 1 diabetes. "It changes your lives completely," Dana Lobel said. "You lose a lot of spontaneity with this disease. Anything your child does can affect his blood sugar. Managing the disease is a lot of responsibility for...

2008-07-08 09:00:12

EpiVax, Inc, a leader in the field of computational immunology, announced today that it has received a grant from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), a division of the National Institutes of Health (NIH), to develop "Epi-13", a novel therapeutic for the prevention and treatment of Type 1 diabetes, a devastating and chronic autoimmune disease that affects three million Americans. NIDDK will provide EpiVax $600,000 over two years to reach...

2008-06-27 12:02:19

INDIANAPOLIS, June 27 /PRNewswire-FirstCall/ -- Media conference call with Gary Hall Jr.: Monday, June 30, 2:00 PM EDT United States: (800) 553-0327 International: +1 (612) 332-0226 When Olympian Gary Hall Jr. was diagnosed with diabetes, his physician prescribed Eli Lilly and Company's fast-acting insulin Humalog(R) (insulin lispro injection [rDNA origin]) to help manage his blood sugar and keep alive his gold-medal dreams -- hopes he fulfilled in the 2000 Sydney Games and...

2008-06-26 12:03:21

Osiris Therapeutics has received $2 million in milestone payments from the Juvenile Diabetes Research Foundation for progress made on a Phase II clinical trial evaluating Prochymal, a mesenchymal stem cell therapy, for patients recently diagnosed with type 1 diabetes. The payments were triggered when Osiris accomplished certain clinical and regulatory milestones including initiating patient treatments. Jay Skyler, professor of medicine and associate director of the Diabetes Research...

2008-06-25 09:02:22

Osiris Therapeutics, Inc. (NASDAQ:OSIR) today announced that it has achieved $2 million in milestone payments from the Juvenile Diabetes Research Foundation (JDRF) for progress made on a Phase II clinical trial evaluating Prochymal, a mesenchymal stem cell (MSC) therapy, for patients recently diagnosed with type 1 diabetes. The payments were triggered when Osiris accomplished certain clinical and regulatory milestones including initiating patient treatments. "Due to the long-term effects of...

c7dd721bb61e51f63f7da5c13b496ab01
2008-04-09 10:24:42

One day it may be possible to mimic the tactics used by parasites to trick the body into accepting transplanted tissues or organs.That is the hope of Dr Shane Grey from the Garvan Institute for Medical Research and Professor John Dalton from the Institute for the Biotechnology of Infectious Diseases at the University of Technology (UTS). The pair has been awarded a $400,000 grant through the Australian Islet Transplantation Program, administered jointly by the Juvenile Diabetes Research...

30ae9b0a5061bf8be259b535d9c6e8161
2008-04-03 11:45:00

Scientists have discovered a new technique for turning embryonic stem cells into insulin-producing pancreatic tissue in what could prove a significant breakthrough in the quest to find new treatments for diabetes.The University of Manchester team, working with colleagues at the University of Sheffield, were able to genetically manipulate the stem cells so that they produced an important protein known as a "Ëœtranscription factor'.Stem cells have the ability to become any type of...

ef3fd410b320c07cb40a6816117f1fee1
2008-01-25 11:55:00

Researchers in Belgium have significantly advanced the discovery of a pancreatic progenitor cell with the capacity to generate new insulin-producing beta cells. If the finding made in mice holds for humans, the newfound progenitor cells may represent "an obvious target for therapeutic regeneration of beta cells in diabetes," the researchers report in the Jan. 25 issue of the research journal Cell, a publication of Cell Press. In people with type 1 diabetes, blood sugar rises due to a loss of...

2007-06-18 06:00:00

Diabetes is a serious disease that is striking hard at 21 million people in the U.S. It knows no professional boundaries... just ask Olympic athlete Kris Freeman, mountain climber Greg Cummings, actress Halle Berry or, if you could, scientist Thomas Edison. Diabetes also knows no age boundaries... it can strike at any age. The Juvenile Diabetes Research Foundation states that in the U.S., three million people have type 1 diabetes. Every year, another 13,000 are newly diagnosed, as early as...